Canaccord Genuity Group Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $7.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price target dropped by investment analysts at Canaccord Genuity Group from $9.50 to $7.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would indicate a potential upside of 25.56% from the stock’s previous close.

Separately, Oppenheimer cut their price target on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Tuesday, January 28th. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $11.25.

Bioceres Crop Solutions Stock Down 0.1 %

Shares of Bioceres Crop Solutions stock traded down $0.01 during trading hours on Friday, reaching $5.58. The company’s stock had a trading volume of 621,461 shares, compared to its average volume of 237,374. The stock’s fifty day simple moving average is $6.65 and its two-hundred day simple moving average is $7.86. The company has a market capitalization of $349.61 million, a P/E ratio of 277.79 and a beta of 0.57. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. Bioceres Crop Solutions has a one year low of $5.50 and a one year high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. During the same period in the prior year, the business posted ($0.07) EPS. On average, research analysts forecast that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of large investors have recently added to or reduced their stakes in BIOX. Ping Capital Management Inc. lifted its holdings in shares of Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after purchasing an additional 3,000 shares during the period. Stifel Financial Corp raised its holdings in shares of Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the period. JPMorgan Chase & Co. increased its position in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after acquiring an additional 29,693 shares in the last quarter. Finally, Fourth Sail Capital LP increased its position in shares of Bioceres Crop Solutions by 16.6% during the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock worth $22,490,000 after acquiring an additional 527,859 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.